Sector
PharmaceuticalsOpen
₹19.13Prev. Close
₹19.13Turnover(Lac.)
₹133.7Day's High
₹19.2Day's Low
₹18.7552 Week's High
₹27.952 Week's Low
₹12.56Book Value
₹3.57Face Value
₹1Mkt Cap (₹ Cr.)
1,780.36P/E
36.5EPS
0.52Divi. Yield
019 Sep 2024
12:00 AM
AGM
Announcement Date: 19 Sep, 2024
13 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 94 | 94 | 91.29 | 88.75 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 192.45 | 162.01 | 130.94 | 98.84 |
Net Worth | 286.45 | 256.01 | 222.23 | 187.59 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 244.8 | 205.51 | 158.63 | 184.82 |
yoy growth (%) | 19.12 | 29.55 | -14.17 | 0.5 |
Raw materials | -161.46 | -151.62 | -108.94 | -128.11 |
As % of sales | 65.95 | 73.77 | 68.68 | 69.31 |
Employee costs | -19.66 | -16.29 | -15.04 | -14.49 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 40.67 | 17.34 | 12.11 | 16 |
Depreciation | -4.03 | -4.06 | -3.72 | -3.12 |
Tax paid | -11.53 | -3.03 | -3.36 | -5.34 |
Working capital | 84.97 | 9.2 | 8.52 | 11.14 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 19.12 | 29.55 | -14.17 | 0.5 |
Op profit growth | 127.39 | 42.55 | -28.62 | -1.5 |
EBIT growth | 130.01 | 43.76 | -24.08 | 0.23 |
Net profit growth | 104.66 | 64.83 | -18.82 | 2.86 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2017 |
|---|---|---|---|---|---|
Gross Sales | 465.01 | 263.39 | 224.25 | 219.66 | 182.75 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 465.01 | 263.39 | 224.25 | 219.66 | 182.75 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 17.44 | 13.53 | 14.61 | 12.02 | 4.86 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,677.5 | 94 | 4,02,584.41 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,859.5 | 82.46 | 1,82,147.28 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,497.6 | 25.13 | 1,20,934.05 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,349.4 | 59.47 | 1,13,319.98 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.8 | 19.84 | 1,06,137.94 | 1,200.7 | 0.63 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Wholetime Director
Kedarmal Bankda
Managing Director
Vijay Shankarlal Bankda
Whole-time Director
Rinki Bankda
Independent Director
Ruchi Jindal
Company Sec. & Compli. Officer
Vaishali Agrawal
Independent Director
Ritesh Kumar Lunkad
Independent Director
Ankit Jain
7 Niraj Indl Estate Andheri(E),
Off Mahakali Caves Rd,
Maharashtra - 400093
Tel: 91-22-30887744
Website: http://www.syncomformulations.com
Email: finance@sfil.in; sfil87@syncomformulations.com
Plot No. 60,
Electronic Complex, Pardeshipura,
Indore - 452010
Tel: 91-0731-3198601/3198
Website: www.ankitonline.org
Email: ankit_4321@yahoo.com
Summary
Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992. The Company in the Indian Pharmaceutical Industry repr...
Read More
Reports by Syncom Formulations (India) Ltd
What is the Syncom Formulations India Ltd share price today?
What is the Market Cap of Syncom Formulations India Ltd?
What is the PE and PB ratio of Syncom Formulations India Ltd?
What is the 52 Week High and Low of Syncom Formulations India Ltd?
What is the CAGR of Syncom Formulations India Ltd?
What is the shareholding pattern of Syncom Formulations India Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.